Skip to main
TBI

TrueBlue (TBI) Stock Forecast & Price Target

TrueBlue (TBI) Analyst Ratings

Based on 1 analyst ratings
Buy
Strong Buy 0%
Buy 100%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

TrueBlue Inc. reported a revenue increase of 2% year-over-year, primarily driven by robust demand for commercial staffing, which experienced double-digit growth. The company's adjusted EBITDA margin improved by 50 basis points to 0.7%, attributed to effective strategic cost actions that align with management forecasts. Additionally, despite facing a challenging organic growth outlook, the reported revenue reflects a resilient operational performance that underscores the stability of its core staffing segments.

Bears say

TrueBlue Inc. has reported a decline in adjusted EBITDA margin of 320 basis points year-over-year to 5.2%, attributing this drop to lower operating leverage and a decrease in organic revenues. The PeopleReady segment, which generates the majority of TrueBlue's revenue, experienced a 5% year-over-year revenue decline, falling short of the projected 3% decrease amidst ongoing softness in client verticals. Additionally, TrueBlue's 2Q25 results reflected an adjusted loss per share of $(0.07), indicating continued challenges in profitability and growth across its segments.

TrueBlue (TBI) has been analyzed by 1 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 100% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of TrueBlue and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About TrueBlue (TBI) Forecast

Analysts have given TrueBlue (TBI) a Buy based on their latest research and market trends.

According to 1 analysts, TrueBlue (TBI) has a Buy consensus rating as of Dec 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $6, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $6, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

TrueBlue (TBI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.